INTERNATIONAL PATENT: BAYER AKTIENGESELLSCHAFT FILES APPLICATION FOR "FUROINDAZOLE DERIVATIVE PHARMACEUTICAL DOSAGE"

GENEVA, Dec. 9 -- BAYER AKTIENGESELLSCHAFT (Kaiser-Wilhelm-Allee 151373 Leverkusen) filed a patent application (PCT/EP2025/064804) for "FUROINDAZOLE DERIVATIVE PHARMACEUTICAL DOSAGE" on May 28, 2025. With publication no. WO/2025/247981, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FADINI, Tommaso (c/o BAYER AKTIENGESELLSCHAFTKaiser-Wilhelm-Allee 151373 Leverkusen), HUIJUN, Chen (c/o BAYER HEALTHCARE CO. LTD7 Rong Jing Dong Jie, Beijing Economic and Technological Development AreaBeijing, Beijing 100176), SACHER, Frank (...